Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Not yet recruiting × eribulin × Clear all

Phase

Phase 2 8 Phase 3 2 Phase 1/2 1

Status

Completed 8 Recruiting 5 Terminated 4 Withdrawn 2 Active not recruiting 2 Unknown 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Injections 15 Bevacizumab 15 Drug Therapy 10 Gemcitabine 8 Cyclophosphamide 8 Paclitaxel 7 venetoclax 6 toripalimab 6 tislelizumab 6 irinotecan sucrosofate 6 Temozolomide 6 Specimen Handling 6 Oxaliplatin 6 Magnetic Resonance Spectroscopy 6 Fluorouracil 6 Carboplatin 6 Biopsy 6 pembrolizumab 5 fludarabine 5 Leucovorin 5 Etoposide 5 Capecitabine 5 sintilimab 4 lenvatinib 4 Radiotherapy 4 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 4 Irinotecan 4 HMPL-013 4 Dexamethasone 4 Cisplatin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07494448 2026-03-27

JAZMINE

MedSIR

Phase 1/2 Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡